Prognostic factors and outcomes of COVID-19 cases in Ethiopia: multi-center cohort study protocol
Open Access
- 16 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12879-021-06652-0
Abstract
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) and became pandemic after emerging in Wuhan, China, in December 2019. Several studies have been conducted to understand the key features of COVID-19 and its public health impact. However, the prognostic factors of COVID-19 are not well studied in the African setting. In this study, we aim to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients in Ethiopia. A multi-center cohort study design will be performed. Patients with confirmed COVID-19 infection admitted to selected treatment centers will be enrolled irrespective of their symptoms and followed-up for 12 months. Baseline epidemiological, clinical, laboratory and imaging data will be collected from treatment records, interviews, physical measurements, and biological samples. Follow-up data collection involves treatment and prognostic outcomes to be measured using different biomarkers and clinical parameters. Data collection will be done electronically using the Open Data Kit (ODK) software package and then exported to STATA/SPSS for analysis. Both descriptive and multivariable analyses will be performed to assess the independent determinants of the treatment outcome and prognosis to generate relevant information for informed prevention and case management. The primary outcomes of this study are death/survival and viral shedding. Secondary outcomes include epidemiological characteristics, clinical features, genetic frequency shifts (genotypic variations), and nutritional status. This is the first large prospective cohort study of patients in hospitals with COVID-19 in Ethiopia. The results will enable us to better understand the epidemiology of SARS-CoV-2 in Africa. This study will also provide useful information for effective public health measures and future pandemic preparedness and in response to outbreaks. It will also support policymakers in managing the epidemic based on scientific evidence. Trial Registration: The Protocol prospectively registered in ClinicalTrials.gov (NCT04584424) on 30 October, 2020.Funding Information
- Ministry of Health, Ethiopia
- International Institute for Primary Heath Care-Ethiopia
This publication has 27 references indexed in Scilit:
- Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory virusesInfluenza and Other Respiratory Viruses, 2018
- Molecular basis for universal HLA-A*0201–restricted CD8 + T-cell immunity against influenza virusesProceedings of the National Academy of Sciences of the United States of America, 2016
- Pathogenesis of Middle East respiratory syndrome coronavirusThe Journal of Pathology, 2014
- A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1)Clinical Infectious Diseases, 2011
- Nutrition, immunity and infection.Published by CABI Publishing ,2010
- Nutrition, immunity and infectionPublished by CABI Publishing ,2010
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- [Ethiopia-Netherlands AIDS research project].2001
- Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?Journal of the American College of Cardiology, 1999
- Nutrition, immunity and infection: From basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survivalProceedings of the National Academy of Sciences of the United States of America, 1996